(36B5) iShares MSCI EM SRI USD - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BGDQ0T50 • Global Emerging Markets Equity

36B5: Emerging Markets, Stocks, Bonds, Equities

The iShares MSCI EM SRI UCITS ETF USD (Dist), traded on XETRA under the ticker symbol 36B5, is a BlackRock-managed fund designed for investors seeking exposure to emerging markets with a focus on sustainability and responsible investing. As part of the iShares family, this ETF leverages BlackRocks global reach and indexing expertise to deliver targeted access to emerging market equities.

The fund tracks the Morningstar EM TME NR USD index, which screens companies for environmental, social, and governance (ESG) criteria. This index excludes firms involved in controversial weapons, tobacco, and fossil fuels, aligning with the growing demand for sustainable investment options. By focusing on ESG-compliant companies, the ETF aims to balance financial returns with positive societal impact.

With an AUM of 3,597.45 million EUR, this ETF represents a significant pooled investment vehicle for institutional and retail investors alike. Its structure as a UCITS-compliant fund ensures regulatory oversight and transparency, making it a viable option for European investors. The fund is domiciled in Ireland, a common jurisdiction for European ETFs due to its favorable regulatory environment.

For investors and fund managers, this ETF offers a way to diversify portfolios with exposure to high-growth emerging markets while integrating ESG considerations. The funds distribution policy ensures regular income through dividend payouts, appealing to investors seeking yield in addition to capital appreciation. However, like all emerging market investments, it comes with risks such as currency fluctuations and political instability.

Overall, the iShares MSCI EM SRI UCITS ETF USD (Dist) serves as a tool for investors to gain exposure to a diversified basket of emerging market equities with a sustainable twist. Its focus on ESG criteria makes it a compelling choice for those aligning their investments with global sustainability goals.

Additional Sources for 36B5 ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

36B5 ETF Overview

Market Cap in USD 3,900m
Category Global Emerging Markets Equity
TER 0.25%
IPO / Inception 2018-12-06

36B5 ETF Ratings

Growth 5y 35.3%
Fundamental -
Dividend 50.2%
Rel. Strength Industry -15.1
Analysts -
Fair Price Momentum 4.73 EUR
Fair Price DCF -

36B5 Dividends

Dividend Yield 12m 2.37%
Yield on Cost 5y 3.56%
Annual Growth 5y 4.78%
Payout Consistency 94.0%

36B5 Growth Ratios

Growth Correlation 3m -12.1%
Growth Correlation 12m 80.7%
Growth Correlation 5y 2.5%
CAGR 5y 8.33%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m 0.08
Alpha -0.44
Beta 0.67
Volatility 17.46%
Current Volume 227.8k
Average Volume 20d 61.9k
What is the price of 36B5 stocks?
As of March 14, 2025, the stock is trading at EUR 4.67 with a total of 227,759 shares traded.
Over the past week, the price has changed by -1.98%, over one month by -6.54%, over three months by -6.48% and over the past year by +5.96%.
Is iShares MSCI EM SRI USD a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares MSCI EM SRI USD (XETRA:36B5) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.25 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of 36B5 as of March 2025 is 4.73. This means that 36B5 is currently overvalued and has a potential downside of 1.28%.
Is 36B5 a buy, sell or hold?
iShares MSCI EM SRI USD has no consensus analysts rating.
What are the forecast for 36B5 stock price target?
According to ValueRays Forecast Model, 36B5 iShares MSCI EM SRI USD will be worth about 5.3 in March 2026. The stock is currently trading at 4.67. This means that the stock has a potential upside of +12.42%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 5.3 12.4%